(19)
(11) EP 2 074 633 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.09.2016 Bulletin 2016/38

(45) Mention of the grant of the patent:
20.07.2016 Bulletin 2016/29

(21) Application number: 07852540.9

(22) Date of filing: 03.10.2007
(51) International Patent Classification (IPC): 
G21F 5/018(2006.01)
G21H 5/02(2006.01)
G21G 4/08(2006.01)
(86) International application number:
PCT/US2007/021344
(87) International publication number:
WO 2008/045298 (17.04.2008 Gazette 2008/16)

(54)

SELF-ALIGNING RADIOISOTOPE ELUTION SYSTEM

SELBSTAUSRICHTENDES RADIOISOTOP-ELUTIONSSYSTEM

SYSTÈME D'ÉLUTION DE RADIOISOTOPES À AUTO-ALIGNEMENT


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 06.10.2006 US 849869 P

(43) Date of publication of application:
01.07.2009 Bulletin 2009/27

(60) Divisional application:
16180032.1

(73) Proprietor: Mallinckrodt Nuclear Medicine LLC
Hazelwood, MO 63042 (US)

(72) Inventors:
  • HORTON, Duane, L.
    St. Louis, MO 63128 (US)
  • SPETH, Andrew, D.
    St. Louis, MO 63123 (US)

(74) Representative: Edson, Russell Gregory 
Withers & Rogers LLP 4 More London Riverside
London SE1 2AU
London SE1 2AU (GB)


(56) References cited: : 
EP-A- 0 739 017
GB-A- 1 473 236
WO-A-2007/016172
US-A- 4 020 351
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).